Exploring the Frontiers of Psychedelic Research: Key Studies That Are Shaping the Future

Psychedelic therapy, particularly involving psilocybin, is emerging as a promising treatment for major depressive disorder (MDD). In this article, we delve into six pivotal studies that highlight the potential and advancements in this field. For those seeking more information, we encourage visiting the linked websites for the studies themselves.

1. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

  • Authors: Davis et al., 2020

  • Summary: This study demonstrates the significant positive effects of psilocybin-assisted therapy on individuals with major depressive disorder, suggesting a new horizon in mental health treatment.

  • Link: Read the full study

2. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

  • Authors: Barrett et al., 2022

  • Summary: Expanding on previous research, this study offers a long-term view, showcasing the sustained benefits and safety of psilocybin therapy over a year.

  • Link: Read the full study

3. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder

  • Authors: Doss et al., 2021

  • Summary: This research highlights how psilocybin therapy can enhance cognitive and neural flexibility, marking a significant leap in treating MDD.

  • Link: Read the full study

4. The costs and benefits of psychedelics on cognition and mood.

  • Authors: Sayali & Barrett, 2023

  • Summary: An insightful examination of the positive and negative impacts of psychedelics, offering a balanced view of their role in mental health.

  • Link: Read the full study

5. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting

  • Authors: Prochazkova et al. 2018

  • Summary: This pioneering study delves into how microdosing psychedelics can potentially enhance creativity, opening new doors in mental health research.

  • Link: Read the full study

6. Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms

  • Authors: Griffiths, Barrett, et al., 2023

  • Summary: This research categorizes psychedelic experiences, linking specific types to distinct effects on depression and anxiety, offering valuable insights for therapy.

  • Link: Read the full study

7. Imperial College London's Groundbreaking Ceremony Study

  • Authors: Carhart-Harris, et al. 2023

  • Summary: Conducted in collaboration with Synthesis Retreat, this study explores the therapeutic potentials of psychedelic ceremonies, contributing significantly to the field.

  • Link: Learn more about the study

The evolving landscape of psychedelic therapy presents a beacon of hope for those struggling with mental health issues, particularly major depressive disorder. At Mirabilis Health Institute, we are committed to staying at the forefront of this promising field.

6 Day Psilocybin Group Retreat

Sparjeburd, Netherlands

Tuesday 7th- Sunday 12th May

Next
Next

Understanding EMDR: What It Is and How It Can Help